("Agronomics" or the "Company")
Agronomics welcomes Hamood Al Fanna as a Senior Investment Associate
Agronomics Limited (AIM:ANIC), a leading listed company focused on cellular agriculture, is pleased to announce the appointment of Hamood Al Fanna, who has joined the Company's advisory team as a Senior Investment Associate. Based in Oman, Hamood was formerly a venture investor at IDO Investments a global investment firm focused on innovative growth stage start-ups. At IDO Investments, Hamood focused on the biotechnology and healthcare sectors. Hamood's arrival will support the advisory team's recommendations to the Company for investments in promising companies in cellular agriculture, and also help raise awareness of cellular agriculture in the Gulf Cooperation Council region, noting the potential of this technology to vastly improve nutrition security in harsher climates, where the majority of food is imported.
Jim Mellon, Non-executive Director of Agronomics commented:-
"We are pleased to welcome Hamood to Agronomics' growing advisory team. His experience of investing in biotech, alongside his passion for cellular agriculture, makes him the perfect candidate to augment the range of expert specialists we now have available to draw upon, and who are placed at the forefront of this fast-moving, and essential, field."
Agronomics is a leading listed alternative proteins company with a focus on cellular agriculture and cultivated meat. The Company has established a portfolio of 20 companies at the Pre-Seed to Series C stage in this rapidly advancing sector. It seeks to secure minority stakes in companies owning technologies with defensible intellectual property that offer new ways of producing food and materials with a focus on products historically derived from animals. These technologies are driving a major disruption in agriculture, offering solutions to improve sustainability, as well as addressing human health, animal welfare and environmental damage. This disruption will decouple supply chains from the environment and animals, as well as being fundamental to feeding the world's expanding population. A full list of Agronomics' portfolio companies is available at https://agronomics.im/ .
About Cellular Agriculture
Cellular Agriculture is the production of agriculture products directly from cells, as opposed to raising an animal for slaughter, or growing crops. This encompasses cell culture to produce cultivated meat and materials, and fermentation processes that harness a combination of molecular biology, synthetic biology, tissue engineering and biotechnology to massively simplify production methods in a sustainable manner.
Over the coming decades, the source of the world's food supply traditionally derived from conventional agriculture is going to change dramatically. We have already witnessed the first wave of this shift with the consumer adoption of plant-based alternative proteins but today, we are on the cusp of an even bigger wave of change. This is being facilitated by advances in cellular agriculture. This change is necessary, given scientists claims that if we maintain existing animal protein consumption patterns, then we will not meet the Paris Agreement's goal of limiting warming to 1.5 ℃
AT Kearney, a global consultancy firm, projects that cultivated meat's market share will reach 35% by 2040. This combined with the Good Food Institute's estimate that a US $1.8 trillion investment will be required in order to produce just 10% of the world's protein using this technology, means that we are on the cusp of a multi-decade flow of capital to build out manufacturing facilities. Funding in the field of cellular agriculture is accelerating, however still less than US$ 2 billion has been invested worldwide since the industry's inception in 2016.
For further information please contact:
Agronomics Limited |
Beaumont Cornish Limited |
Cenkos Securities Plc |
Peterhouse Capital Limited |
TB Cardew |
The Company |
Nomad |
Joint Broker |
Joint Broker |
Public Relations |
Richard Reed Denham Eke |
Roland Cornish James Biddle |
Giles Balleny Michael Johnson |
Lucy Williams Charles Goodfellow |
Ed Orlebar Joe McGregor |
+44 (0) 1624 639396 |
+44 (0) 207 628 3396 |
+44 (0) 207 397 8900 |
+44 (0) 207 469 0936 |
+44 (0) 20 7930 0777 +44 (0) 7738 724 630 |